| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.04 | 0.8 |